Big Data and Collaboration Seek to Fight Covid-19

Feb 1, 2021 | Conduits News

As part of a consortium, Mount Sinai’s ConduITS, the Clinical Translational Science Award (CTSA) of ISMMS, supported by the National Center for Advancing Translational Science (NCATS), a division of the National Institutes of Health will offer as a resource to our investigators access to (N3C) and in the future the COMBATCOVID database a cross-institution collaborative.

The most ambitious effort in the United States is the National COVID Cohort Collaborative (N3C) database. The database is collecting information from electronic health records of patients who have been tested for COVID-19—whether those tests came back positive or negative—or who have reported COVID-like symptoms. Health care providers submit the records and NCATS makes them available for any credentialed researcher to analyze.

COMBATCOVID which is part of N3C and will bring together electronic health records (EHR) data from multiple participating institutions into a shared centralized database. As part of the COMBATCOVID effort, biospecimens data of COVID-19 patients collected by some of the participating institutions will also be shared and linked to the respective EHR data.

For further information for Mount Sinai researchers regarding the N3C data enclave and the COMBATCOVID consortium, please contact: Anar Poltinnikov at: Anar.Poltinnikov@mountsinai.org

Study Purpose
The purpose of this study is to create a data registry of all inpatients and outpatients across all participating centers from January 1, 2020 to December 31, 2022 in order to further understand and characterize illness due to the novel coronavirus (COVID-19 disease).

Primary Objective
To establish an active data registry of patients across health institutions and partnered Clinical Research Networks (CRN) to gather data on COVID-19 related symptomology, comorbidities, risk factors, diagnoses, clinical findings and outcomes.

Data Source
Data sets from participating health centers and other CRN (Clinical Research Networks) will be shared with NYU Langone Health and uploaded into a central data registry maintained by NYU Langone Health (on site).

ConduITS is supported by NCATS of the NIH’s CTSA Program. Any use of CTSA-supported resources requires citation of grant number UL1TR001433.

Recent ConduITS News

What is the Mount Sinai Exposomics Core?

The Mount Sinai Exposomics Core centers around The Institute for Exposomic Research at the Icahn School of Medicine at Mount Sinai, which was established in 2017 under the leadership of Robert O. Wright, MD, MPH and Rosalind J. Wright, MD, MPH, international leaders...

read more

What does the Exposomics Core do?

The Exposomics Core is at the cutting edge of research to quantify the exposome (i.e., nutrition, social risk factors, and chemical exposure) via lab assays, geospatial modeling, data mining and artificial intelligence. We disseminate our work to cultivate the public...

read more

Highlighted Exposomics Core Events

In 2025, the Exposomics Core was a part of multiple events, including: Lunchtime Chat Webinars (held throughout the year) On January 8, 2025, Maayan Yitshak-Sade, PhD, MPH (Associate Professor, Department of Environmental Medicine, Icahn School of Medicine at Mount...

read more

Exposomics Core Highlighted Information

More information on faculty and staff updates can be found in the departmental newsletters, which are sent out throughout the year. Below are the most recent editions from 2025: December 2025 July 2025 April 2025 The Institute for Exposomic Research is also on...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Dr. Lee 2025 KL2 Scholar

Dr. Lee 2025 KL2 Scholar

Dr. Lee is an Assistant Professor in the Division of Surgical Oncology. Her proposal is titled ‘Generating a Multimodal Machine Learning Model for Prediction of Thyroid Cancer Recurrence’. Her mentors will be: Girish Nadkarni, MD, MPH, Michael Marin, MD, and Gerald...

read more
Dr. Xiaoqi 2025 KL2 Scholar

Dr. Xiaoqi 2025 KL2 Scholar

Dr. Xiaoqi is an Assistant Professor in the Department of Immunology and Immunotherapy. His proposal is titled ‘Nanoparticle STING Immunotherapy Against TP53-Mutated Acute Myeloid Leukemia’. His mentors will be: Brian Brown, PhD, and Joshua Brody, MD.  Dr. Xiaoqi is...

read more